Liver carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Screening by quantitative reverse-transcription PCR and PCR arrays revealed that cyclin E1, CDK2, Fos and Jun were negatively regulated by ARNT, whereas CDKN1C, CNKN2A, CDKN2B, MAPK11 and MAPK14 were positively regulated in HCC.
|
21544813 |
2012 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Presence of SB202190, the p38 MAPK inhibitor, attenuates the anti-metastatic potential of genipin in hepatocellular carcinoma.
|
23029478 |
2012 |
Liver carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We have previously shown that the p38 MAPK inhibitor SB203580 (SB) significantly induced Cyp1a1 gene expression at the mRNA and activity levels, whereas it dramatically inhibited the induction of Cyp1a1 by TCDD in murine hepatoma Hepa 1c1c7 cells.
|
21732638 |
2011 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We thus demonstrate a mechanistic cascade of ATX-producing LPA with LPA activating LPA1 and inducing MMP-9 through coordinate activation of the PI3K and the p38 MPAK signaling cascades, providing novel biomarkers and potential therapeutic targets for HCC.
|
21102517 |
2011 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells.
|
19497411 |
2009 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion.
|
18167130 |
2008 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells.
|
17483345 |
2007 |
Liver carcinoma
|
0.100 |
PosttranslationalModification
|
disease |
BEFREE |
Our results strongly suggest that activation of PKCdelta regulates the phosphorylation of HSP27 via p38 MAPK in human HCC.
|
17673262 |
2007 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells.
|
16951197 |
2006 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
FACL4 is involved in the HCC tumorigenesis and both cAMP and p38 MAPK pathways are associated with the regulation of FACL4 in HCC.
|
15849811 |
2005 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
LHGDN |
FACL4 is involved in the HCC tumorigenesis and both cAMP and p38 MAPK pathways are associated with the regulation of FACL4 in HCC.
|
15849811 |
2005 |
Liver carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We analysed the involvement of MAPK homologues in IL-6 transduction pathways and found that interleukin-6 triggered activation of p38 stress-activated protein kinase (p38) but not of jun kinase. p38 activity was required for biological functions including acute phase protein secretion from HepG2 hepatoma and proliferation of B9 hybridoma cells.
|
10445852 |
1999 |